Phase 1 Metastatic Hormone Sensitive Prostate Cancer trials recruiting now

All Metastatic Hormone Sensitive Prostate Cancer trials, every phase

Phase 1 Metastatic Hormone Sensitive Prostate Cancer trials

• A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
  NCT05818683 · Phase: Phase 1 · Ages: 18 Years and older · Sex: Male · 15 locations
• A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer
  NCT07339267 · Phase: Phase 1 · Ages: 18 Years to 85 Years · Sex: Male · 1 location
• Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study).
  NCT05720130 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · 3 locations

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.